Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2

被引:106
作者
Miller, JD
Weber, DA
Ibegbu, C
Pohl, J
Altman, JD
Jensen, PE
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Emory Vaccine Res Ctr, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Microchem Facil, Atlanta, GA 30322 USA
关键词
D O I
10.4049/jimmunol.171.3.1369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The MHC class Ib molecule HLA-E is the primary ligand for CD94/NKG2A-inhibitory receptors expressed on NK cells, and there is also evidence for TCR-mediated recognition of this molecule. HLA-E preferentially assembles with a homologous set of peptides derived from the leader sequence of class la molecules, but its capacity to bind and present other peptides remains to be fully explored. The peptide-binding motif of HLA-E was investigated by folding HLA-E in vitro in the presence of peptide libraries derived from a nonameric leader peptide sequence randomized at individual anchor positions. A high degree of selectivity was observed at four of five total anchor positions, with preference for amino acids present in HLA-E-binding peptides from class la leader sequences. Selectivity was also observed at the nonanchor P5 position, with preference for positively charged amino acids, suggesting that electrostatic interactions involving the P5 side chain may facilitate assembly of HLA-E peptide complexes. The observed HLA-E peptide-binding motif was strikingly similar to that previously identified for the murine class lb molecule, Qa-1. Experiments with HLA-E tetramers bearing peptides substituted at nonanchor positions demonstrated that P5 and P8 are primary contact residues for interaction with CD94/NKG2 receptors. A conservative replacement of Arg for Lys at P5 completely abrogated binding to CD94/NKG2. Despite conservation of peptide-binding specificity in HLA-E and Qa-1, cross-species tetramer-staining experiments demonstrated that the interaction surfaces on CD94/NKG2 and the class Ib ligands have diverged between primates and rodents.
引用
收藏
页码:1369 / 1375
页数:7
相关论文
共 50 条
[1]   IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN [J].
ALDRICH, CJ ;
DECLOUX, A ;
WOODS, AS ;
COTTER, RJ ;
SOLOSKI, MJ ;
FORMAN, J .
CELL, 1994, 79 (04) :649-658
[2]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[3]   Primate Mhc-E and -G alleles [J].
ArnaizVillena, A ;
MartinezLaso, J ;
Alvarez, M ;
Castro, MJ ;
Varela, P ;
GomezCasado, E ;
Suarez, B ;
Recio, MJ ;
VargasAlarcon, G ;
Morales, P .
IMMUNOGENETICS, 1997, 46 (04) :251-266
[4]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[5]  
BOYSON JE, 1995, IMMUNOGENETICS, V41, P59
[6]   Spontaneous eye movements during visual imagery reflect the content of the visual scene [J].
Brandt, SA ;
Stark, LW .
JOURNAL OF COGNITIVE NEUROSCIENCE, 1997, 9 (01) :27-38
[7]   TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide [J].
Braud, VM ;
Allan, DSJ ;
Wilson, D ;
McMichael, AJ .
CURRENT BIOLOGY, 1998, 8 (01) :1-10
[8]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[9]  
Brooks AG, 1999, J IMMUNOL, V162, P305
[10]   A major histocompatibility complex class I allele shared by two species of chimpanzee [J].
Cooper, S ;
Adams, EJ ;
Wells, RS ;
Walker, CM ;
Parham, P .
IMMUNOGENETICS, 1998, 47 (03) :212-217